1. 2000 болезней от А до Я. Справочник‑путеводитель. - М.: ГЭОТАР, 1998-2002.
2. Ackerman A.B. Histologic diagnosis of inflammatory skin diseases. - Baltimore: Williams and Wilkins, 1997.
3. Anton R., Brown R.W., Younes M., Gondo M., Stephenson M. Absence of prognostic significance of bcl2 immunopositivity in non‑small cell lung cancer: analysis of 427 cases. - Modern Pathology. - 1996. - P.153A.
4. Arends and Wylli. Apoptosis mechanisms and its roles in pathology // Int. Rev. Exp. Pathol. - 1991. - Vol. 32. - Р. 223-254.
5. Aschoff K.A.L. Zur Myokarditisfrage // Verhandlungen der deutschen pathologischen Gesellschaft. - 1904. - Vol. 8. - Р. 46-53.
6. Bell D.A., Weinstock M.A., Scully R.E. Peritoneal implants of ovarian boderline tumors: histologic features and prognosis // Cancer. - 1988. - Vol. 62. - P. 2212-2222.
7. Bell D.A. Ovarian surface epithelial‑stromal tumors // Human Pathol. - 1991. - Vol. 22. - P. 750-762.
8. Bettinger H.F., Reagan J.W. (Chairmen). Proceeding of the International Committe on Histological Terminology for lesions of the uterine cervix // In: Proc.1st Int. Congress Exfol. Cytol. (Vienna, 1961). - Philadelphia, 1962.
8а. Beutler B. Orchestration of septic shock by cytokines: the role of cachectin (tumor necrosis factor) // In: Mollecular and cellular mechanisms of septic shock. - N.Y.: Alan R. Liss. - 1989. - P. 219-235.
8б. Biglieri E.G. A prismatic case: 17‑alpha‑hydroxylase deficiency: 1963-1966 // J. Clin. Endocr. Metab. - Vol. 82. - Р. 48-50, 1997; Biglieri E.G., Herron M.A., Brust N. 17‑Hydroxylation deficiency in man // J. Clin. Invest. - Vol. 45. - 1946-1954, 1966.
9. Bigner D.D., McLendon R.E., Bruner J.M. (eds). Russel and Rubinstein’s pathology of tumors of the nervous system. - 6th ed. - London: Arnold, 1998.